Innovation in Gastroenterology & Hepatology

Purnima Bhat 

Purnima Bhat is a gastroenterologist/hepatologist and immunology scientist at the Canberra Hospital and Australian National University. She is the current Chair of the World Endoscopy Organisation African Outreach Committee. Her research investigates gut-liver interactions in gastrointestinal, metabolic, and inflammatory disorders. She has published over 30 original research articles and reviews in scientific journals including Nature Medicine, Gut, Cell Death & Disease, Molecular Cell Biology, Digestive Endoscopy, PLOS Pathogens, and Journal of Virology, and she holds two patents derived from her work. Her ongoing projects traverse the spectrum of science to bedside care from immune regulatory pathways in colon cancer and liver disease, to translational medicine in the development of affordable point-of-care tests, and GI health delivery and teaching in low-resourced and remote environments. 

Knut E A Lundin 

Knut E A Lundin is Professor of Medicine and Head of Clinical Education, Faculty of Medicine, University of Oslo, Norway and senior consultant gastroenterologist at the endoscopy unit at Oslo University Hospital, Rikshospitalet. He works with Professor Ludvig M Sollid on the immunobiology and clinical aspects of coeliac disease (CeD). His seminal paper in Journal of Experimental Medicine in 1993 on gluten specific T cells from the small intestine has led to in-detail dissection of the immunopathogenesis of the disease. Focus has also been paid to non-coeliac gluten sensitivity, “regular” and “complicated” CeD, refractory CeD, inflammatory bowel disease, clinical nutrition and other GI disorders in a tertiary referral hospital setting. He has training in all aspects of diagnostic and therapeutic endoscopy.  

He initiated the International Society for the Study of Celiac Disease in 2011 and the European Society for Study of Coeliac Disease in 2015. He was senior author of the recent guidelines from the European Society for Study of Coeliac Disease published in UEG Journal in 2019 and downloaded more than 100.000 times. He has published more than 200 papers as original papers, reviews and book chapters and has been cited in > 26.000 other publications, his h-index is 77 and the i10-index 206. 

Henning Grønbæk 

Henning Grønbæk is a clinician-scientist with extensive expertise in inflammatory liver diseases, including metabolic dysfunction–associated steatotic liver disease (MASLD/MASH), autoimmune liver diseases and primary liver cancer. His research has centered on the immunopathogenesis of chronic liver disease, with a particular focus on macrophage biology and macrophage-derived biomarkers as tools for assessing disease severity, treatment response, and prognosis. 

Professor Grønbæk has extensive experience in research leadership and talent development, having supervised >50 research year and PhD students across the full spectrum of academic project execution. His scientific work has appeared in leading international journals, including Nature Reviews Gastroenterology & Hepatology, Journal of Hepatology, Nature Communications, and Nature Genetics. 

Expert Review of Gastroenterology & Hepatology is a MEDLINE-indexed, peer-reviewed Open Select journal. It publishes state-of-the-art research and clinical advancements in our pathological, biochemical and physiological understanding of gastrointestinal and hepatological diseases. The journal also provides up-to-the-minute developments in strategies for prevention, diagnosis and intervention. Part of our Expert Collection series. 
– Journal Impact Factor (2024): 2.5 
– Offers Accelerated Publication and Plain Language Summaries of Publication 
– Editors in Chief: Professors Paul Martin, University of Miami, USA and James Tabibian, David Geffen School of Medicine at UCLA, USA 
– Each review includes an Expert Opinion and Article Highlights section. 
– Also publishes: Systematic Reviews, Meta-analyses, Original Research, Reviews, Drug Profiles, Clinical Trial Reports, Special Reports, Meeting Reports, Letters to the Editor, Key Paper Evaluations, Critical Perspectives, Clinical Trial Protocols, Presentation Extracts, and Poster Extracts. 
– Commissioning Contact: Liv Clovis-Corbett

Gastrointestinal Oncology: Management and Care is a multidisciplinary, open access, peer reviewed journal publishing novel and confirmatory research on the prevention, detection, treatment, and management of all gastrointestinal cancers. The journal aims to disseminate evidence-based research to a range of medical specialists and improve patient outcomes through a multidisciplinary care approach.  
– Article Processing Charge: Taylor & Francis are currently supporting a 100% APC discount for all authors. 
– Offers Data Notes, Registered Reports, and Methods 
– Also accepts Research Articles, Review Articles, Article Commentaries, Reports, Case Reports and Letters to the Editor 
– Editor in Chief: Professor Janusz Jankowski, University College London, UK 

– Commissioning Contact: Victoria Ruhle

Scandinavian Journal of Gastroenterology is a broad scope, Open Select, peer-reviewed journal publishing patient-oriented research on gastroenterology and hepatology and focusing on surgery, endoscopy and internal medicine, now in its 60^th volume. 
– Journal Impact Factor (2024): 1.6 
– Offers Accelerated Publication 
– We are supporting Page Charge Waivers for all commissioned papers in this journal 
– Accepts Research Articles, Review Articles, Brief Reports, and Article Commentaries 
– Editor in Chief: Professor Reidar Fossmark, Norwegian University of Science and Technology and St. Olav’s Hospital, Norway 
– Commissioning Contact: Patrick Wall

Clinical and Experimental Gastroenterologyis a broad scope, Open Access, peer-reviewed journal publishing on gastrointestinal disease in the liver, gall bladder and pancreas, including pathology, pharmacology, immunology and genomics. Part of our Dove Medical Press series. 
– Journal Impact Factor (2024): 2.3 
– Article Processing Charge: $3,300 
– Offers Podcasts 
– Full list of article types is available here  
– Editor in Chief: Professor Andreas M. Kaiser, City of Hope National Medical Center, USA 
– Commissioning Contact: Becky Kearns

Hepatic Medicine: Evidence and Research is a broad scope, Open Access, peer-reviewed journal publishing on adult and paediatric hepatology, focusing on the pathology, pathophysiology, treatment and pharmacology of hepatic disease. Part of our Dove Medical Press series.  
– Journal Impact Factor (2024): 2.6 
– Article Processing Charge: $2,990 
– Offers Podcasts 
– Full list of article types is available here  
– Editor in Chief: Dr Gerond Lake-Bakaar, Beth Israel Deaconess Medical Center, Harvard Medical School, USA 
– Commissioning Contact: Becky Kearns

Colorectal Cancer is an open-access peer-reviewed journal that provides novel insights into development, prevention, cancer biology and treatments by offering reviews, analysis and commentary on all aspects of colorectal cancer. The journal is ideal for the busy clinician or healthcare professional who requires a concise, readable overview of current and future management options in this fast-moving field. Part of our Expert Medicine series. 
– Journal Impact Factor (2024): 0.3 
– Article Processing Charge: $2,195 
– Offers Accelerated Publication and Plain Language Summaries of Publication 
– Publishes Podcasts, Patient Perspectives and How I Treat 
– Partnered with Oncology Central digisite 
– Editor in Chief: Professor Heinz-Josef Lenz, University of Southern California, USA 
– Commissioning Contact: George Leung
– Also publishes: Case Reports/Series, Clinical Trial Evaluations, Clinical Trial Protocols, Commentaries, Drug Evaluations, Interviews, Journal Watch, Letter to the Editor, Meta-analyses, Perspectives, Research Articles, Reviews, Systematic Reviews, White Papers, Meeting Reports, Device Evaluations, Methods, and Special Reports. 

Hepatic Oncology is a fully open-access, peer-reviewed journal publishing original research studies and reviews addressing preventive, diagnostic and therapeutic approaches to all types of cancer of the liver, in adult and pediatric populations. The journal highlights significant advances in basic and translational research, and places them in context for future therapy. Hepatic Oncology original research studies, reviews, commentaries, interviews, drug evaluations and plain language summaries of publication. Part of our Expert Medicine series. 
– Journal Impact Factor (2024): 1.3 
– Article Processing Charge: $2,195 
– Offers Accelerated Publication, Plain Language Summaries of Publication and Podcasts 
– Editor in Chief: Professor Richard Finn, David Geffen School of Medicine at University of California Los Angeles, USA 
– Also publishes: Case Reports/Series, Clinical Trial Evaluations, Clinical Trial Protocols, Drug Evaluations, Interviews, Journal Watch, Letter to the Editor, Meta-analyses, Perspectives, Reviews, Systematic Reviews, Vaccines Evaluations, White Papers, Article Commentaries, Profiles, Meeting Reports, Device Evaluations, Methods, Key Paper Evaluations, and Special Reports. 
– Commissioning Contact: George Leung